The Role of Race in Thyroid Cancer Systematic Review Pdf

1. Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, et al. 2015 American Thyroid Association direction guidelines for developed patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Clan guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid 2016;26(one):1-133.

   

2. Grossman DC, Back-scratch SJ, Barry MJ, Davidson KW, et al; US Preventive Services Task Force; Bibbins-Domingo K. Screening for thyroid cancer: US Preventive Services Task Force recommendation statement. JAMA 2017;317(xviii):1882-7.

   

3. International Agency for Research on Cancer. Thyroid health monitoring afterwards nuclear accidents. Lyon, France: IARC Publications, 2018.

4. Merlo DF, Filiberti R, Kobernus Thou, Bartonova A, Gamulin M, Ferencic Z, et al. Cancer risk and the complication of the interactions between environmental and host factors: HENVINET interactive diagrams as uncomplicated tools for exploring and agreement the scientific evidence. Environ Health 2012;11 Suppl 1:S9.

   

5. Pellegriti G, Frasca F, Regalbuto C, Squatrito S, Vigneri R. Worldwide increasing incidence of thyroid cancer: update on epidemiology and chance factors. J Cancer Epidemiol 2013;2013:965212.

   

6. Bergman A, Heindel JJ, Jobling S, Kidd KA, Zoeller RT. State of the scientific discipline of endocrine disrupting chemicals - 2012. Earth Wellness Arrangement, Un Environment Programme (WHO-UNEP); 2012.

   

7. United Nations Scientific Committee on the Effects of Atomic Radiation. UNSCEAR 2008 report to the general associates with scientific annexes. Annex D: Health furnishings due to radiation from the Chernobyl blow. New York: United Nations; 2011. p.219.

8. Chen AY, Jemal A, Ward EM. Increasing incidence of differentiated thyroid cancer in the United States, 1988-2005. Cancer 2009;115(16):3801-7.

   

9. Ahn HS, Welch HG. South korea's thyroid-cancer 'epidemic'--turning the tide. N Engl J Med 2015;373(24):2389-xc.

   

10. Vaccarella S, Dal Maso L, Laversanne 1000, Bray F, Plummer M, Franceschi Southward. The impact of diagnostic changes on the ascent in thyroid cancer incidence: a population-based study in selected high-resource countries. Thyroid 2015;25(ten):1127-36.

    

11. Lim H, Devesa SS, Sosa JA, Check D, Kitahara CM. Trends in thyroid cancer incidence and mortality in the United States, 1974-2013. JAMA 2017;317(xiii):1338-48.

    

12. Bray F, Colombet M, Mery L, Piñeros Grand, Znaor A, Zanetti R, et al. Cancer incidence in five continents, Vol. XI (electronic version). Lyon, France: International Bureau for Enquiry on Cancer; 2017 .

13. Qian ZJ, Jin MC, Meister KD, Megwalu UC. Pediatric thyroid cancer incidence and mortality trends in the U.s., 1973-2013. JAMA Otolaryngol Head Neck Surg 2019;145(vii):617-23.

    

14. McNally RJ, Blakey K, James PW, Gomez Pozo B, Basta NO, Hale J. Increasing incidence of thyroid cancer in Great britain, 1976-2005: age-period-cohort assay. Eur J Epidemiol 2012;27(8):615-22.

    

15. Cho YY, Jang HW, Joung JY, Park SM, Jeong DJ, Kim SW, et al. Trends in thyroid cancer incidence in Korean Children (1999-2012) based on palpation and nonpalpation detection methods. Eur Thyroid J 2015;4(iv):252-nine.

    

16. Fukunaga FH, Yatani R. Geographic pathology of occult thyroid carcinomas. Cancer 1975;36(3):1095-9.

    

17. Harach HR, Franssila KO, Wasenius VM. Occult papillary carcinoma of the thyroid. A 'normal' finding in Republic of finland. A systematic autopsy study. Cancer 1985;56(3):531-viii.

    

18. Furuya-Kanamori L, Bong KJL, Clark J, Glasziou P, Doi SAR. Prevalence of differentiated thyroid cancer in autopsy studies over six decades: a meta-assay. J Clin Oncol 2016;34(xxx):3672-9.

    

19. Ahn HS, Kim HJ, Welch HG. Korea'south thyroid-cancer 'epidemic'--screening and overdiagnosis. N Engl J Med 2014;371(19):1765-seven.

    

20. Ahn HS, Kim HJ, Kim KH, Lee YS, Han SJ, Kim Y, et al. Thyroid cancer screening in South korea increases detection of papillary cancers with no bear on on other subtypes or thyroid cancer mortality. Thyroid 2016;26(11):1535-40.

    

21. Choi YM, Kim WG, Kwon H, Jeon MJ, Han Grand, Kim TY, et al. Changes in standardized mortality rates from thyroid cancer in Korea between 1985 and 2015: analysis of Korean national data. Cancer 2017;123(24):4808-14.

    

22. Jeon MJ, Kim HK, Kim EH, Kim ES, Yi HS, Kim TY, et al. Decreasing disease-specific mortality of differentiated thyroid cancer in Korea: a multicenter accomplice study. Thyroid 2018;28(ix):1121-7.

    

23. Sprague BL, Warren Andersen S, Trentham-Dietz A. Thyroid cancer incidence and socioeconomic indicators of wellness care access. Cancer Causes Control 2008;19(six):585-93.

    

24. Morris LG, Sikora AG, Tosteson TD, Davies Fifty. The increasing incidence of thyroid cancer: the influence of access to intendance. Thyroid 2013;23(7):885-91.

    

25. Udelsman R, Zhang Y. The epidemic of thyroid cancer in the United States: the role of endocrinologists and ultrasounds. Thyroid 2014;24(3):472-9.

    

26. Enewold L, Zhu 1000, Ron Due east, Marrogi AJ, Stojadinovic A, Peoples GE, et al. Rise thyroid cancer incidence in the U.s. by demographic and tumor characteristics, 1980-2005. Cancer Epidemiol Biomarkers Prev 2009;xviii(3):784-91.

    

27. Pathak KA, Leslie WD, Klonisch TC, Nason RW. The irresolute face of thyroid cancer in a population-based accomplice. Cancer Med 2013;2(4):537-44.

    

28. Lin JS, Bowles EJA, Williams SB, Morrison CC. Screening for thyroid cancer: updated evidence written report and systematic review for the U.s.a. Preventive Services Task Strength. JAMA 2017;317(eighteen):1888-903.

    

29. Jung YS, Oh CM, Kim Y, Jung KW, Ryu J, Won YJ. Long-term survival of patients with thyroid cancer according to the methods of tumor detection: a nationwide cohort study in Korea. PLoS Ane 2018;xiii(4):e0194743.

    

30. Ron Eastward, Modan B, Preston D, Alfandary Due east, Stovall M, Boice JD Jr. Thyroid neoplasia post-obit low-dose radiation in babyhood. Radiat Res 1989;120(3):516-31.

    

31. Ron Due east, Lubin JH, Shore RE, Mabuchi M, Modan B, Pottern LM, et al. Thyroid cancer after exposure to external radiations: a pooled analysis of seven studies. Radiat Res 1995;141(iii):259-77.

    

32. Sigurdson AJ, Ronckers CM, Mertens Air conditioning, Stovall M, Smith SA, Liu Y, et al. Primary thyroid cancer later on a first tumour in babyhood (the Childhood Cancer Survivor Study): a nested instance-control study. Lancet 2005;365(9476):2014-23.

    

33. Risks to the thyroid from ionizing radiation. Bethesda, MD: National Council on Radiations Protection and Measurement; 2009.

    

34. Sinnott B, Ron E, Schneider AB. Exposing the thyroid to radiation: a review of its electric current extent, risks, and implications. Endocr Rev 2010;31(5):756-73.

    

35. Shore RE, Woodard E, Hildreth Due north, Dvoretsky P, Hempelmann Fifty, Pasternack B. Thyroid tumors following thymus irradiation. J Natl Cancer Inst 1985;74(6):1177-84.

    

36. Favus MJ, Schneider AB, Stachura ME, Arnold JE, Ryo UY, Pinsky SM, et al. Thyroid cancer occurring as a late issue of caput-and-neck irradiation. Evaluation of 1056 patients. N Engl J Med 1976;294(19):1019-25.

    

37. United Nations Scientific Committee on the Effects of Atomic Radiation, UNSCEAR 2008 Written report. Sources and effects of ionizing radiation. Volume I: Sources. Written report to the general assembly with scientific annexes A and B.

    

38. Veiga LH, Holmberg East, Anderson H, Pottern L, Sadetzki South, Adams MJ, et al. Thyroid cancer later childhood exposure to external radiation: an updated pooled analysis of 12 studies. Radiat Res 2016;185(5):473-84.

    

39. Mettler FA Jr, Thomadsen BR, Bhargavan M, Gilley DB, Gray JE, Lipoti JA, et al. Medical radiation exposure in the U.S. in 2006: preliminary results. Health Phys 2008;95(5):502-seven.

    

40. Mettler FA Jr, Mahesh M, Bhargavan-Chatfield Thousand, Chambers CE, Elee JG, Frush DP, et al. Patient exposure from radiologic and nuclear medicine procedures in the United States: procedure book and effective dose for the period 2006-2016. Radiology 2020;295(2):418-27.

    

41. Ionizing radiation exposure of the population of the U.s.a.. Bethesda, MD: the National Council on Radiation Protection and Measurement; 2009.

42. das Bundesamt f㉨r Strahlenschutz.

    

43. Leswick DA, Hunt MM, Webster ST, Fladeland DA. Thyroid shields versus z-centrality automatic tube current modulation for dose reduction at neck CT. Radiology 2008;249(2):572-80.

    

44. Tipnis SV, Spampinato MV, Hungerford J, Huda W. Thyroid doses and risks to adult patients undergoing neck CT examinations. AJR Am J Roentgenol 2015;204(5):1064-viii.

    

45. Abuzaid MM, Elshami Westward, Haneef C, Alyafei S. Thyroid shield during brain CT scan: dose reduction and epitome quality evaluation. Imaging Med 2017;9(3):45-8.

46. Visweswaran S, Kanagaraj G, Joseph S, Perumal Five. Medical imaging: contribution toward groundwork radiation and human exposure. J Radiat Cancer Res 2018;nine(four):177-82.

    

47. Dawson P, Punwani S. The thyroid dose burden in medical imaging A re-examination. Eur J Radiol 2009;69(1):74-9.

    

48. Zhang Y, Chen Y, Huang H, Sandler J, Dai M, Ma S, et al. Diagnostic radiography exposure increases the run a risk for thyroid microcarcinoma: a population-based case-control study. Eur J Cancer Prev 2015;24(5):439-46.

    

49. Hong JY, Han K, Jung JH, Kim JS. Association of exposure to diagnostic low-dose ionizing radiation with risk of cancer among youths in Republic of korea. JAMA Netw Open 2019;2(ix):e1910584.

    

50. Memon A, Godward Due south, Williams D, Siddique I, Al-Saleh K. Dental x-rays and the adventure of thyroid cancer: a case-control study. Acta Oncol 2010;49(4):447-53.

    

51. Wingren Grand, Hallquist A, Hardell L. Diagnostic 10-ray exposure and female papillary thyroid cancer: a pooled analysis of two Swedish studies. Eur J Cancer Prev 1997;six(half-dozen):550-6.

    

52. Preston-Martin South, Thomas DC, White SC, Cohen D. Prior exposure to medical and dental x-rays related to tumors of the parotid gland. J Natl Cancer Inst 1988;80(12):943-9.

    

53. Preston-Martin S, White SC. Brain and salivary gland tumors related to prior dental radiography: implications for electric current do. J Am Dent Assoc 1990;120(2):151-viii.

    

54. Hallquist A, Hardell L, Degerman A, Boquist Fifty. Occupational exposures and thyroid cancer: results of a case-control study. Eur J Cancer Prev 1993;ii(4):345-nine.

    

55. Zabel EW, Alexander BH, Mongin SJ, Doody MM, Sigurdson AJ, Linet MS, et al. Thyroid cancer and employment as a radiologic technologist. Int J Cancer 2006;119(8):1940-5.

    

56. American Dental Clan Council on Scientific Diplomacy. The use of dental radiographs: update and recommendations. J Am Dent Assoc 2006;137(9):1304-12.

    

57. Han MA, Kim JH. Diagnostic Ten-ray exposure and thyroid cancer risk: systematic review and meta-analysis. Thyroid 2018;28(2):220-viii.

    

58. Nagataki Southward, Nystrom E. Epidemiology and primary prevention of thyroid cancer. Thyroid 2002;12(x):889-96.

    

59. Socolow EL, Hashizume A, Neriishi S, Niitani R. Thyroid carcinoma in human being after exposure to ionizing radiation. A summary of the findings in Hiroshima and Nagasaki. N Engl J Med 1963;268:406-ten.

    

60. Furukawa K, Preston D, Funamoto S, Yonehara S, Ito M, Tokuoka S, et al. Long-term trend of thyroid cancer risk among Japanese diminutive-bomb survivors: 60 years after exposure. Int J Cancer 2013;132(v):1222-6.

    

61. Thompson DE, Mabuchi Yard, Ron E, Soda M, Tokunaga Chiliad, Ochikubo S, et al. Cancer incidence in atomic flop survivors. Function Two: Solid tumors, 1958-1987. Radiat Res 1994;137(2 Suppl):S17-67.

    

62. Lund E, Galanti MR. Incidence of thyroid cancer in Scandinavia post-obit fallout from atomic bomb testing: an analysis of birth cohorts. Cancer Causes Control 1999;10(3):181-7.

    

63. WHO. 1986-2016: Chernobyl at thirty. An update. 2016.

64. Hatch Yard, Cardis Due east. Somatic wellness effects of Chernobyl: 30 years on. Eur J Epidemiol 2017;32(12):1047-54.

    

65. Kazakov VS, Demidchik EP, Astakhova LN. Thyroid cancer afterwards Chernobyl. Nature 1992;359(6390):21.

    

66. Drozd VM, Astakhova LN, Polyanskaya ON, Kobzev VF, Nalivko Equally, Tolkachev YV. Ultrasonic diagnostics of thyroid pathology in children and adolescents affected by radionuclides. Proceedings of the 6th International Congress on Interventional Ultrasound. University of Copenhagen: Denmark; 1993. p.110-one.

67. Cardis Eastward, Kesminiene A, Ivanov V, Malakhova I, Shibata Y, Khrouch V, et al. Risk of thyroid cancer later exposure to 131I in childhood. J Natl Cancer Inst 2005;97(ten):724-32.

    

68. Jacob P, Bogdanova TI, Buglova Due east, Chepurniy Grand, Demidchik Y, Gavrilin Y, et al. Thyroid cancer amongst Ukrainians and Belarusians who were children or adolescents at the time of the Chernobyl accident. J Radiol Prot 2006;26(i):51-67.

    

69. Jacob P, Bogdanova TI, Buglova E, Chepurniy Thou, Demidchik Y, Gavrilin Y, et al. Thyroid cancer risk in areas of Ukraine and Belarus affected by the Chernobyl accident. Radiat Res 2006;165(1):1-8.

    

70. Davis S, Stepanenko V, Rivkind Due north, Kopecky KJ, Voilleque P, Shakhtarin V, et al. Risk of thyroid cancer in the Bryansk Oblast of the Russia after the Chernobyl Power Station accident. Radiat Res 2004;162(3):241-8.

    

71. Astakhova LN, Anspaugh LR, Beebe GW, Bouville A, Drozdovitch VV, Garber V, et al. Chernobyl-related thyroid cancer in children of Belarus: a case-control study. Radiat Res 1998;150(3):349-56.

    

72. Tronko Dr., Howe GR, Bogdanova TI, Bouville AC, Epstein OV, Brill AB, et al. A cohort report of thyroid cancer and other thyroid diseases after the chornobyl accident: thyroid cancer in Ukraine detected during first screening. J Natl Cancer Inst 2006;98(xiii):897-903.

    

73. Little MP, Kukush AG, Masiuk SV, Shklyar S, Carroll RJ, Lubin JH, et al. Impact of uncertainties in exposure assessment on estimates of thyroid cancer risk amid Ukrainian children and adolescents exposed from the Chernobyl accident. PLoS One 2014;9(1):e85723.

    

74. Zablotska LB, Ron E, Rozhko AV, Hatch M, Polyanskaya ON, Brenner AV, et al. Thyroid cancer risk in Belarus amidst children and adolescents exposed to radioiodine after the Chornobyl accident. Br J Cancer 2011;104(1):181-7.

    

75. Zablotska LB, Nadyrov EA, Rozhko AV, Gong Z, Polyanskaya ON, McConnell RJ, et al. Analysis of thyroid malignant pathologic findings identified during 3 rounds of screening (1997-2008) of a cohort of children and adolescents from belarus exposed to radioiodines later the Chernobyl accident. Cancer 2015;121(iii):457-66.

    

76. World Health System. Health consequences of the Chernobyl accident: results of the IPHECA pilot projects and related national programmes: scientific report. Geneva: WHO Printing, 1996. p.519.

77. International Commission on Radiological Protection. Awarding of the Committee'south recommendations for the protection of people in emergency exposure situations. ICRP Publication 109. Ann ICRP 2009;39(i).

78. Kaiser JC, Jacob P, Blettner K, Vavilov S. Screening effects in risk studies of thyroid cancer after the Chernobyl accident. Radiat Environ Biophys 2009;48(2):169-79.

    

79. Mangano JJ. Geographic variation in U.S. thyroid cancer incidence and a cluster almost nuclear reactors in New Jersey, New York, and Pennsylvania. Int J Health Serv 2009;39(4):643-61.

    

80. Levin RJ, De Simone NF, Slotkin JF, Henson BL. Incidence of thyroid cancer surrounding three mile isle nuclear facility: the thirty-yr follow-up. Laryngoscope 2013;123(viii):2064-71.

    

81. Desbiolles A, Roudier C, Goria Due south, Stempfelet 1000, Kairo C, Quintin C, et al. Cancer incidence in adults living in the vicinity of nuclear power plants in French republic, based on data from the French Network of Cancer Registries. Int J Cancer 2018;142(5):899-909.

    

82. Davis S, Kopecky KJ, Hamilton TE, Onstad LE, King BL, Saporito MS, et al. Hanford thyroid affliction study final written report. Seattle, Washington: Fred Hutchinson Cancer Research Center; 2002 .

83. Kim J, Bang Y, Lee WJ. Living nearly nuclear power plants and thyroid cancer risk: a systematic review and meta-analysis. Environ Int 2016;87:42-8.

    

84. Douglas AJ, Omar RZ, Smith PG. Cancer mortality and morbidity amongst workers at the Sellafield constitute of British Nuclear Fuels. Br J Cancer 1994;70(half-dozen):1232-43.

    

85. International Atomic Energy Bureau. The Fukushima Daiichi accident; 2015. ; 2015

86. Ivanov VK, Kashcheev VV, Chekin SY, Maksioutov MA, Tumanov KA, Vlasov OK, et al. Radiation-epidemiological studies of thyroid cancer incidence in Russian federation after the Chernobyl accident (estimation of radiations risks, 1991-2008 follow-upward period). Radiat Prot Dosimetry 2012;151(three):489-99.

    

87. Likhtarov I, Kovgan L, Vavilov S, Chepurny Yard, Ron E, Lubin J, et al. Post-Chernobyl thyroid cancers in Ukraine. Study 2: risk analysis. Radiat Res 2006;166(ii):375-86.

    

88. Suzuki S, Matsumoto Y, Ookouchi C, Nakano K, Iwadate M, Suzuki S, et al. The clinicopathological features of childhood and adolescent thyroid cancer in Fukushima afterwards the Fukushima Daiichi nuclear ability plant accident. Thyroid 2018;Supplement one(Affiche 136).

    

89. Suzuki S, Bogdanova TI, Saenko VA, Hashimoto Y, Ito M, Iwadate M, et al. Histopathological analysis of papillary thyroid carcinoma detected during ultrasound screening examinations in Fukushima. Cancer Sci 2019;110(two):817-27.

    

90. Fridman M, Savva N, Krasko O, Mankovskaya S, Branovan DI, Schmid KW, et al. Initial presentation and late results of handling of post-Chernobyl papillary thyroid carcinoma in children and adolescents of Belarus. J Clin Endocrinol Metab 2014;99(eight):2932-41.

    

91. Yamashita S, Suzuki S, Suzuki S, Shimura H, Saenko Five. Lessons from Fukushima: latest findings of thyroid cancer later on the Fukushima Nuclear Ability Constitute blow. Thyroid 2018;28(1):11-22.

    

92. Kim E, Kurihara O, Kunishima N, Momose T, Ishikawa T, Akashi M. Internal thyroid doses to Fukushima residents-estimation and problems remaining. J Radiat Res 2016;57 Suppl 1:i118-i26.

    

93. International Agency for Research on Cancer. The comprehensive interactive data prepare of cancer incidence in five continents.

94. Keane Eastward, Francis EC, Cathain EO, Rowley H. The role of race in thyroid cancer: systematic review. J Laryngol Otol 2017;131(half-dozen):480-6.

    

95. Nose V. Familial thyroid cancer: a review. Mod Pathol 2011;24 Suppl 2:S19-33.

    

96. Jasperson KW, Patel SG, Ahnen DJ. APC-associated polyposis conditions. In: Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens Grand, editors. GeneReviews. Seattle (WA), Usa: University of Washington, Seattle, 2017.

97. Eng C. PTEN hamartoma tumor syndrome. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Edible bean LJH, Stephens K, editors. GeneReviews. Seattle (WA), USA: University of Washington, Seattle, 2001.

98. Khan NE, Bauer AJ, Schultz KAP, Doros L, Decastro RM, Ling A, et al. Quantification of thyroid cancer and multinodular goiter risk in the DICER1 syndrome: a family-based accomplice written report. J Clin Endocrinol Metab 2017;102(five):1614-22.

    

99. Gudmundsson J, Thorleifsson Grand, Sigurdsson JK, Stefansdottir L, Jonasson JG, Gudjonsson SA, et al. A genome-wide association study yields 5 novel thyroid cancer risk loci. Nat Commun 2017;8:14517.

    

100. Takahashi M, Saenko VA, Rogounovitch TI, Kawaguchi T, Drozd VM, Takigawa-Imamura H, et al. The FOXE1 locus is a major genetic determinant for radiation-related thyroid carcinoma in Chernobyl. Hum Mol Genet 2010;xix(12):2516-23.

     

101. McTiernan AM, Weiss NS, Daling JR. Incidence of thyroid cancer in women in relation to reproductive and hormonal factors. Am J Epidemiol 1984;120(3):423-35.

     

102. Levi F, Franceschi South, Gulie C, Negri E, La Vecchia C. Female thyroid cancer: the office of reproductive and hormonal factors in Switzerland. Oncology 1993;50(4):309-15.

     

103. Kilfoy BA, Devesa SS, Ward MH, Zhang Y, Rosenberg PS, Holford TR, et al. Gender is an age-specific outcome modifier for papillary cancers of the thyroid gland. Cancer Epidemiol Biomarkers Prev 2009;18(four):1092-100.

     

104. Faria CC, Peixoto MS, Carvalho DP, Fortunato RS. The emerging role of estrogens in thyroid redox homeostasis and carcinogenesis. Oxid Med Cell Longev 2019;2019:2514312.

     

105. Liang L, Zheng XC, Hu MJ, Zhang Q, Wang SY, Huang F. Association of benign thyroid diseases with thyroid cancer risk: a meta-assay of prospective observational studies. J Endocrinol Invest 2019;42(6):673-85.

     

106. Kitahara CM, Farkas DKR, Jorgensen JOL, Cronin-Fenton D, Sorensen HT. Benign thyroid diseases and risk of thyroid cancer: a nationwide cohort study. J Clin Endocrinol Metab 2018;103(half dozen):2216-24.

     

107. Steele CB, Thomas CC, Henley SJ, Massetti GM, Galuska DA, Agurs-Collins T, et al. Vital signs: trends in incidence of cancers associated with overweight and obesity - United States, 2005-2014. MMWR Morb Mortal Wkly Rep 2017;66(39):1052-8.

     

108. Centers for Disease Control and Prevention. 2017.

109. Schmid D, Ricci C, Behrens G, Leitzmann MF. Adiposity and risk of thyroid cancer: a systematic review and meta-analysis. Obes Rev 2015;16(12):1042-54.

     

110. Zimmermann MB, Galetti V. Iodine intake as a adventure factor for thyroid cancer: a comprehensive review of animal and human studies. Thyroid Res 2015;8:8.

     

111. Bacher-Stier C, Riccabona Grand, Totsch M, Kemmler One thousand, Oberaigner W, Moncayo R. Incidence and clinical characteristics of thyroid carcinoma afterward iodine prophylaxis in an endemic goiter country. Thyroid 1997;7(5):733-41.

     

112. Lind P, Langsteger Due west, Molnar M, Gallowitsch HJ, Mikosch P, Gomez I. Epidemiology of thyroid diseases in iodine sufficiency. Thyroid 1998;8(12):1179-83.

     

113. Kovacs GL, Gonda G, Vadasz G, Ludmany E, Uhrin K, Gorombey Z, et al. Epidemiology of thyroid microcarcinoma found in autopsy serial conducted in areas of different iodine intake. Thyroid 2005;fifteen(2):152-7.

     

114. Cao LZ, Peng XD, Xie JP, Yang FH, Wen HL, Li S. The relationship between iodine intake and the risk of thyroid cancer: a meta-analysis. Medicine (Baltimore) 2017;96(twenty):e6734.

     

115. Lee JH, Hwang Y, Vocal RY, Yi JW, Yu HW, Kim SJ, et al. Human relationship between iodine levels and papillary thyroid carcinoma: a systematic review and meta-analysis. Head Neck 2017;39(eight):1711-eight.

     

116. Kitahara CM, Linet MS, Beane Freeman LE, Check DP, Church TR, Park Y, et al. Cigarette smoking, alcohol intake, and thyroid cancer chance: a pooled analysis of five prospective studies in the United States. Cancer Causes Control 2012;23(10):1615-24.

     

117. Galanti MR, Hansson L, Lund Eastward, Bergstrom R, Grimelius 50, Stalsberg H, et al. Reproductive history and cigarette smoking as risk factors for thyroid cancer in women: a population-based example-control study. Cancer Epidemiol Biomarkers Prev 1996;5(vi):425-31.

     

118. Rossing MA, Cushing KL, Voigt LF, Wicklund KG, Daling JR. Adventure of papillary thyroid cancer in women in relation to smoking and alcohol consumption. Epidemiology 2000;11(1):49-54.

     

119. Kreiger N, Parkes R. Cigarette smoking and the risk of thyroid cancer. Eur J Cancer 2000;36(15):1969-73.

     

120. Karrasch S, Ernst K, Behr J, Heinrich J, Huber RM, Nowak D, et al. Exhaled nitric oxide and influencing factors in a random population sample. Respir Med 2011;105(five):713-eight.

     

121. Bommarito L, Migliore Due east, Bugiani Chiliad, Heffler E, Guida G, Bucca C, et al. Exhaled nitric oxide in a population sample of adults. Respiration 2008;75(four):386-92.

     

122. Russo One thousand, Malandrino P, Moleti M, D'Angelo A, Tavarelli M, Sapuppo G, et al. Thyroid cancer in the pediatric age in Sicily: influence of the volcanic environment. Anticancer Res 2017;37(3):1515-22.

     

123. Kung TM, Ng WL, Gibson JB. Volcanoes and carcinoma of the thyroid: a possible clan. Arch Environ Wellness 1981;36(5):265-7.

     

124. Arnbjornsson East, Arnbjornsson A, Olafsson A. Thyroid cancer incidence in relation to volcanic action. Arch Environ Wellness 1986;41(1):36-forty.

     

125. Kristbjornsdottir A, Rafnsson V. Incidence of cancer amid residents of loftier temperature geothermal areas in Iceland: a census based study 1981 to 2010. Environ Wellness 2012;11:73.

     

126. Clero East, Leux C, Brindel P, Truong T, Anger A, Teinturier C, et al. Pooled analysis of two example-control studies in New Caledonia and French Polynesia of body mass alphabetize and differentiated thyroid cancer: the importance of body surface expanse. Thyroid 2010;20(11):1285-93.

     

127. Zhang Y, Guo GL, Han X, Zhu C, Kilfoy BA, Zhu Y, et al. Practice polybrominated diphenyl ethers (PBDEs) increase the risk of thyroid cancer? Biosci Hypotheses 2008;one(4):195-9.

     

128. Lerro CC, Koutros S, Andreotti G, Sandler DP, Lynch CF, Louis LM, et al. Cancer incidence in the Agronomical Health Report after 20 years of follow-up. Cancer Causes Control 2019;thirty(4):311-22.

     

129. Ward MH, Jones RR, Brender JD, de Kok TM, Weyer PJ, Nolan BT, et al. Drinking water nitrate and human health: an updated review. Int J Environ Res Public Health 2018;15(7):1557.

     

130. Drozd VM, Saenko VA, Brenner AV, Drozdovitch 5, Pashkevich 6, Kudelsky AV, et al. Major factors affecting incidence of childhood thyroid cancer in Republic of belarus after the Chernobyl accident: do nitrates in drinking water play a role? PLoS Ane 2015;ten(9):e0137226.

     

131. Drozd VM, Branovan I, Shiglik N, Biko J, Reiners C. Thyroid cancer induction: nitrates equally independent chance factors or run a risk modulators afterward radiation exposure, with a focus on the Chernobyl blow. Eur Thyroid J 2018;vii(2):67-74.

     

132. Poulsen R, Cedergreen Due north, Hayes T, Hansen Chiliad. Nitrate: an environmental endocrine disruptor? A review of evidence and research needs. Environ Sci Technol 2018;52(7):3869-87.

     

133. Davidson EA, David MB, Galloway JN, Goodale CL, Haeuber R, Harrison JA, et al. Excess nitrogen in the U.S. environment: trends, risks, and solutions. Issues Ecol 2011;15:1-16.

134. Vitousek PM, Aber JD, Howarth RW, Likens GE, Matson PA, Schindler DW, et al. Homo amending of the global nitrogen cycle: Sources and consequences. Ecol Appl 1997;7:737-50.

     

135. National Primary Drinking Water Regulations: Inorganic Chemicals.

136. Ward MH, Kilfoy BA, Weyer PJ, Anderson KE, Folsom AR, Cerhan JR. Nitrate intake and the risk of thyroid cancer and thyroid disease. Epidemiology 2010;21(3):389-95.

     

137. Xie L, Mo 1000, Jia HX, Liang F, Yuan J, Zhu J. Clan betwixt dietary nitrate and nitrite intake and sitespecific cancer risk: evidence from observational studies. Oncotarget 2016;seven(35):56915-32.

     

138. Temkin A, Evans Southward, Manidis T, Campbell C, Naidenko OV. Exposure-based assessment and economic valuation of adverse nativity outcomes and cancer risk due to nitrate in United States drinking water. Environ Res 2019;176:108442.

     

139. Orita Yard, Iyama G, Hayashida N, Mitsutake N, Suzuki S, Yamashita S, et al. Implication of Nitrate in Drinking H2o in Kawauchi Hamlet, Fukushima. Thyroid 2015;25(9):1064-5.

     

140. Drozd V, Branovan I, Platonova T, Shiglik N, Biko J, Reiners C. Nitrates impact on the prevalence of radiation induced thyroid cancer in rural and urban populations of Belarus among the children who were born before and after the Chernobyl accident. Program of the 88th Almanac Meeting of the American Thyroid association. Washington DC, 2018. Thyroid 2018;Supplement 1:28. (Abstract).

141. A web module produced past Commission 3 of the International Commission on Radiological Protection (ICRP).

142. American College of Radiology. 10 things physicians and patients should question.

143. WHO. Iodine thyroid blocking: guidelines for utilize in planning for and responding to radiological and nuclear emergencies. Geneva, Switzerland: Earth Health Organization; 2017a .

haynesandur1970.blogspot.com

Source: https://www.ijthyroid.org/journal/view.html?doi=10.11106%2Fijt.2020.13.2.95